Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-24T00:03:17.617Z Has data issue: false hasContentIssue false
  • English
  • Français

Conocimiento de los problemas metabólicos de los pacientes con trastorno bipolar: encuesta a psiquiatras europeos

Published online by Cambridge University Press:  12 May 2020

Michael Bauer ,
Yves Lecrubier  and
Trisha Suppes
Michael Bauer
Affiliation:
Departamento de Psiquiatría y Psicología, Hospital Universitario Carl Gustav Carus, Universidad Politécnica de Dresde, Fetscherstrasse 74, D-01307Dresde, Alemania
Yves Lecrubier
Affiliation:
INSERM U302, Hospital de la Salpètrière, 47 Boulevard de l'Hôpital, 75013, París, Francia
Trisha Suppes
Affiliation:
Programa de Investigación del Trastorno Bipolar, Departamento de Psiquiatría, Centro Médico del Sudoeste, Universidad de Tejas, 5323 Harry Hines Boulevard, Dallas, Tx 75390-9121, Estados Unidos
Get access

Resumen

Objetivo

Evaluación mediante encuesta en internet del conocimiento del síndrome metabólico de los psiquiatras europeos y su influencia en el tratamiento del trastorno bipolar.

Materiales y métodos

Psiquiatras del Reino Unido, Francia, Alemania, España, y Italia fueron encuestados desde abril a junio de 2006. Los criterios de elegibilidad fueron 4-30 años de ejercicio de la profesión, ≥50% del tiempo dedicado a la atención directa del paciente y haber visto ≥10 pacientes con trastorno bipolar durante el mes anterior. Los datos agregados se ponderaron para representar a la población de médicos en ejercicio de cada país.

Resultados

El 56% de los 718 que respondieron había diagnosticado el síndrome metabólico. Los que respondieron afirmaron que la prevalencia del síndrome metabólico era mayor en los pacientes con trastromo bipolar (25,1%) que en la población general (20%). El 72% consideraba que el síndrome metabólico suponía un riesgo significativo para la salud, que exigía control/tratamiento, y estaban muy preocupados con los efectos adversos de la medicación bipolar, como aumento de peso, deterioro cognitivo e intolerancia a la glucosa. Los que respondieron a la encuesta reconocieron diferencias claras entre los distintos psicotrópicos en la propensión a inducir efectos metabólicos adversos. El 65% de los que respondieron indicó que ellos habían hecho cambios en la entrevista y en el control en los tres últimos años como consecuencia de los problemas metabólicos.

Conclusiones

Los psiquiatras europeos consideran el síndrome metabólico sumamente frecuente en la población general y en pacientes con trastromo bipolar; dos terceras partes de ellos cambiaron su tratamiento de los pacientes con trastromo bipolar por problemas metabólicos.

Keywords

Trastornos maníacos y bipolaresPsiquiatría en Europa
Type
Artículo original
Information
European Psychiatry (Ed. Española) , Volume 15 , Issue 6 , September 2008 , pp. 273 - 282
Copyright
Copyright © European Psychiatric Association 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

[1]Alberti, GIntroduction to the metabolic syndrome. Eur Heart J 2005;7:D3–5.CrossRefGoogle Scholar
[2]Aronne, LJSegal, KRWeight gain in the treatment of mood disorders. J Clin Psychiatry 2003;64(Suppl. 8):22–9.Google ScholarPubMed
[3]Balkau, BCharles, MADrivsholm, TBorch-Johnsen, KWareham, NYudkin, JS et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364–76.Google Scholar
[4]Basu, RBrar, JSChengappa, KNJohn, VParepally, HGershon, S et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder—bipolar subtype. Bipolar Disord 2004;6: 314–8.Google ScholarPubMed
[5]Bosello, OZamboni, MVisceral obesity and metabolic syndrome. Obes Rev 2000;1:47–56.CrossRefGoogle ScholarPubMed
[6]Bowden, CLCalabrese, JRMcEkoy, SLGyulai, LWassef, APetty, F et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481–9.CrossRefGoogle ScholarPubMed
[7]Bowden, CLCalabrese, JRSachs, GYatham, LNAsghar, SAHompland, M et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392–400.CrossRefGoogle ScholarPubMed
[8]Cassidy, FAhearn, ECarroll, BJElevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417–20.Google ScholarPubMed
[9]Citrome, LBlonde, LDamatarca, CMetabolic issues in patients with severe mental illness. South Med J 2005;98:714–20.Google ScholarPubMed
[10]Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039–57.Google Scholar
[11]American Diabetes Associatior, The American Psychiatric Association, The American Association of Clinical Endocrinologists, The North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596–601.CrossRefGoogle Scholar
[12]World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. 1999;99.2:1–66.Google Scholar
[13]Deshmukh, RFranco, KManaging weight gain as a side effect of antidepressant therapy. Cleve Clin J Med 2003;70. 614, 616, 618, passim.Google Scholar
[14]Elmslie, JLMann, JISilverstone, JTWilliams, SMRomans, SEDeterminants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001;62:486–91.CrossRefGoogle ScholarPubMed
[15]Fagiolini, AFrank, EScott, JATurkin, SKupfer, DJMetabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005;7:424–30.CrossRefGoogle ScholarPubMed
[16]Fagiolini, AKupfer, DJHouck, PRNovick, DMFrank, EObesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;160:112–7.CrossRefGoogle ScholarPubMed
[17]Fava, M.Weight gain and antidepressants. J Clin Psychiatry 2000; 61(Suppl. 11):37–41.Google ScholarPubMed
[18]Grant, BFHasin, DSChou, SPStinson, FSDawson, DANicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004;61:1107–15.CrossRefGoogle ScholarPubMed
[19]Grundy, SMCleeman, JIDaniels, SRDonato, KAEckel, RHFranklin, BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735–52.CrossRefGoogle ScholarPubMed
[20]Hu, GQiao, QTuomilehto, JBalkau, BBorch-Johnsen, KPyorala, KPrevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066–76.CrossRefGoogle ScholarPubMed
[21]International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome; 2005.Google Scholar
[22]Isomaa, BAlmgren, PTuomi, TForsen, BLahti, KNissen, M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9.CrossRefGoogle ScholarPubMed
[23]Kalarchian, MAMarcus, MDLevine, MDHaas, GLGreeno, CGWeissfeld, LA et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005;66:1058–63.CrossRefGoogle ScholarPubMed
[24]Keck, PEMcElroy, SLBipolar disorder, obesity, and pharmacotherapyassociated weight gain. J Clin Psychiatry 2003;64:1426–35.CrossRefGoogle ScholarPubMed
[25]Ketter, TAHaupt, DWPerceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice. Curr Med Res Opin 2006;22:2345–53.CrossRefGoogle ScholarPubMed
[26]Ketter, TAKalali, AHWeisler, RHA 6-month, multicenter, openlabel evaluation of beaded, extended-ralease carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004;65:668–73.CrossRefGoogle ScholarPubMed
[27]Kilbourne, AMCornelius, JRHan, XPincus, HAShad, MSalloum, I et al. Burden of general medical conditions among individuais with bipolar disorder. Bipolar Disord 2004;6:368–73.CrossRefGoogle Scholar
[28]Kolotkin, RLCrosby, RDCorey-Lisle, PKLi, HSwanson, JMPerformance of a weight-related measure of quality of life in a psychiatric sample. Qual Life Res 2006;15:587–96.CrossRefGoogle Scholar
[29]Kroger, SShugar, GCooke, RGComorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder. Int J Eat Disord 1996;19:45–52.3.0.CO;2-W>CrossRefGoogle Scholar
[30]Laaksonen, DELakka, HMNiskanen, LKKaplan, GASalonen, JTLakka, TAMetabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070–7.CrossRefGoogle ScholarPubMed
[31]Lakka, HMLaaksonen, DELakka, TANiskanen, LKKumpusalo, ETuomilehto, J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 2002;288:2709–16.CrossRefGoogle ScholarPubMed
[32]Malhotra, SMcElroy, SLAssociations between metabolic syndrome and psychiatric disorder. Prim Psychiatry 2003;10:37–44.Google Scholar
[33]Marken, PAPies, RWEmerging treatments for bipolar disorder: safety and adverse effect profiles (CE) (February). Ann Pharmacother 2006;40:276–85.CrossRefGoogle Scholar
[34]McElroy, SLFrye, MASuppes, TDhavale, DKeck, PE JrLeverich, GS et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207–13.CrossRefGoogle ScholarPubMed
[35]McElroy, SLKotwal, R, Keck, PE Jr, Akiskal, HS. Comorbidity of bipolar and eating disorders: distinct or relatad disorders with shared dysregulations? J Affect Disord 2005;86:107–27.CrossRefGoogle ScholarPubMed
[36]Morriss, RMohammed, FAMetabolism, lifestyle and bipolar affective disorder. J Psychopharmacol 2005;19:94–101.CrossRefGoogle ScholarPubMed
[37]Ramacciotti, CEPaoli, RAMarcacci, GPiccinai, ABurgalassi, ADell'Osso, L et al. Relationship between bipolar illness and bingeeating disorders. Psychiatry Res 2005;135:165–70.CrossRefGoogle Scholar
[38]Sachs, GBowden, CCalabrese, JRKetter, TThompson, TWhite, R et al. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disord 2006;8:175–81.CrossRefGoogle ScholarPubMed
[39]Saely, CHAczel, SMarte, TLanger, PHoefle, GDrexel, HThe metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 2005; 90:5698–703.CrossRefGoogle ScholarPubMed
[40]Suppes, TMcElroy, SHirschfeld, RAwareness of metabolic concerns in patients with bipolar disorder: a survey of 500 US psychiatrists. Psychopharmacol Bull 2007;40:22–37.Google ScholarPubMed
[41]Taylor, VMacqueen, GAssociations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 2006;67:1034–41.CrossRefGoogle ScholarPubMed
[42]Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3140–1.CrossRefGoogle Scholar
[43]Thompson, WKKupfer, DJFagiolini, AScott, JAFrank, EPrevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry 2006;67:783–8.CrossRefGoogle ScholarPubMed
[44]Vornik, LABrown, ESManagement of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 2006;67(Suppl. 7):24-30.Google ScholarPubMed
[45]Wildes, JEMarcus, MDFagiolini, AObesity in patients with bipolar disorder: a biopsychosocial—behavioral modal. J Clin Psychiatry 2006;67:904–15.CrossRefGoogle Scholar
[46]Yusuf, SHawken, SOunpuu, SBautista, LFranzosi, MGCommerford, P et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case—control study. Lancet 2005;366:1640–9.CrossRefGoogle ScholarPubMed